Regeneus Announces Successful Results in Acne Study

Tuesday, 6 February 2018
  • Sygenus topical gel improves the appearance of acne in adults
  • Sygenus gel was well tolerated when applied twice daily for 6 weeks
  • Significant reduction seen in the appearance of non-inflammatory lesions such as blackheads and whiteheads, and inflammatory papules
  • Significant reduction noted in acne global severity score at 6 weeks

The tolerance study, performed by RCTS, a dermatology testing company in Texas, aimed to look at the tolerability of Sygenus in 33 healthy volunteers with mild to moderate facial acne. The study endpoints to assess tolerability involved the change in acne lesions over the 6-week period. Sygenus gel was applied topically twice a day throughout the study. No intolerance was observed and there was an overall improvement in the appearance of acne, as early as 3 weeks. Statistically significant reductions in the total number of inflammatory and non-inflammatory acne lesions were noted from baseline to week 6. Further the acne global severity score showed significant reduction (improvement) at week 6 compared to baseline.